Literature DB >> 24781194

Regulatory T cells and their roles in immune dysregulation and allergy.

Laurence Pellerin1, Jennifer A Jenks, Philippe Bégin, Rosa Bacchetta, Kari C Nadeau.   

Abstract

The main function of the immune system is to fight off potential infections, but also to maintain its activity below a level that would trigger self-reactivity. Regulatory T cells (Tregs) such as forkhead box P3(+) (FOXP3) Tregs and type 1 regulatory T cells (Tr1) play an essential role in this active process, using several distinct suppressive mechanisms. A wide range of pathologies have been associated with altered Treg cell function. This is best exemplified by the impact of mutations of genes essential for Treg function and the associated autoimmune syndromes. This review summarizes the main features of different subtypes of Tregs and focuses on the clinical implications of their altered function in human studies. More specifically, we discuss abnormalities affecting FOXP3(+) Tregs and Tr1 cells that will lead to autoimmune manifestations and/or allergic reactions, and the potential therapeutic use of Tregs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781194      PMCID: PMC4161462          DOI: 10.1007/s12026-014-8512-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  123 in total

1.  Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.

Authors:  Cecilia Oderup; Lukas Cederbom; Anna Makowska; Corrado M Cilio; Fredrik Ivars
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

Review 2.  Apoptosis in tissue inflammation and allergic disease.

Authors:  Cezmi A Akdis; Kurt Blaser; Mübeccel Akdis
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

Review 3.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

4.  Cell-based therapeutics: the next pillar of medicine.

Authors:  Michael A Fischbach; Jeffrey A Bluestone; Wendell A Lim
Journal:  Sci Transl Med       Date:  2013-04-03       Impact factor: 17.956

5.  XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma.

Authors:  Khoa D Nguyen; Alison Fohner; Jerome D Booker; Chen Dong; Alan M Krensky; Kari C Nadeau
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

6.  The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.

Authors:  J-H Lee; H-H Yu; L-C Wang; Y-H Yang; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

7.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

8.  Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.

Authors:  Laura Passerini; Sara Di Nunzio; Silvia Gregori; Eleonora Gambineri; Massimiliano Cecconi; Markus G Seidel; Giantonio Cazzola; Lucia Perroni; Alberto Tommasini; Silvia Vignola; Luisa Guidi; Maria G Roncarolo; Rosa Bacchetta
Journal:  Eur J Immunol       Date:  2011-03-14       Impact factor: 5.532

9.  Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.

Authors:  Jennifer A Jenks; Scott Seki; Takahiro Kanai; Jennifer Huang; Alexander A Morgan; Renata C Scalco; Ruhi Nath; Robert Bucayu; Jan M Wit; Waleed Al-Herz; Dina Ramadan; Alexander A Jorge; Rosa Bacchetta; Vivian Hwa; Ron Rosenfeld; Kari C Nadeau
Journal:  Clin Immunol       Date:  2013-05-05       Impact factor: 3.969

10.  The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.

Authors:  Silvia Gregori; Kevin S Goudy; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2012-02-29       Impact factor: 7.561

View more
  34 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Three Novel Candidate Probiotic Strains with Prophylactic Properties in a Murine Model of Cow's Milk Allergy.

Authors:  Elodie Neau; Johanne Delannoy; Candice Marion; Charles-Henry Cottart; Chantal Labellie; Sophie Holowacz; Marie-José Butel; Nathalie Kapel; Anne-Judith Waligora-Dupriet
Journal:  Appl Environ Microbiol       Date:  2016-01-04       Impact factor: 4.792

3.  Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets.

Authors:  John F Ryan; Rachel Hovde; Jacob Glanville; Shu-Chen Lyu; Xuhuai Ji; Sheena Gupta; Robert J Tibshirani; David C Jay; Scott D Boyd; R Sharon Chinthrajah; Mark M Davis; Stephen J Galli; Holden T Maecker; Kari C Nadeau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

4.  IBD. Regulatory T cells for treatment of Crohn's disease.

Authors:  Azucena Salas; Julián Panés
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-21       Impact factor: 46.802

Review 5.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance.

Authors:  Hanyu Zeng; Rong Zhang; Boquan Jin; Lihua Chen
Journal:  Cell Mol Immunol       Date:  2015-06-08       Impact factor: 11.530

Review 6.  Mucosal immune tolerance at the ocular surface in health and disease.

Authors:  Jeremías G Galletti; Mauricio Guzmán; Mirta N Giordano
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

7.  Engineered ovalbumin-expressing regulatory T cells protect against anaphylaxis in ovalbumin-sensitized mice.

Authors:  Maha Abdeladhim; Ai-Hong Zhang; Laura E Kropp; Alyssa R Lindrose; Shivaprasad H Venkatesha; Edward Mitre; David W Scott
Journal:  Clin Immunol       Date:  2019-07-17       Impact factor: 3.969

8.  Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction.

Authors:  Shok Ping Lim; Benedetta Costantini; Syed A Mian; Pilar Perez Abellan; Shreyans Gandhi; Marc Martinez Llordella; Juan Jose Lozano; Rita Antunes Dos Reis; Giovanni A M Povoleri; Thanos P Mourikis; Ander Abarrategi; Linda Ariza-McNaughton; Susanne Heck; Jonathan M Irish; Giovanna Lombardi; Judith C W Marsh; Dominique Bonnet; Shahram Kordasti; Ghulam J Mufti
Journal:  Blood       Date:  2020-08-13       Impact factor: 22.113

9.  Endogenous Regulatory T Cells Promote M2 Macrophage Phenotype in Diabetic Stroke as Visualized by Optical Imaging.

Authors:  Yu Cai; Ting-Ting Xu; Chun-Qiang Lu; Yuan-Yuan Ma; Di Chang; Yi Zhang; Xiao-Chun Gu; Shenghong Ju
Journal:  Transl Stroke Res       Date:  2020-04-02       Impact factor: 6.829

10.  Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation.

Authors:  Andrea Pennati; Spencer Ng; Yuanqiang Wu; Jordan R Murphy; Jiusheng Deng; Srikant Rangaraju; Seneshaw Asress; Jennifer L Blanchfield; Brian Evavold; Jacques Galipeau
Journal:  J Neurosci       Date:  2016-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.